Comparison of effects of two drugs (magnesium sulphate and nalbuphine) given along with bupivacaine for spinal anaesthesia in patients undergoing lower limb and lower abdominal surgeries .
Not yet recruiting
- Conditions
- Other disorders of the musculoskeletal system and connective tissue, (2) ICD-10 Condition: K45||Other abdominal hernia, (3) ICD-10 Condition: K35-K38||Diseases of appendix, (4) ICD-10 Condition: N30-N39||Other diseases of the urinary system,
- Registration Number
- CTRI/2020/08/027400
- Lead Sponsor
- Dr Bhavana
- Brief Summary
Comparison of intrathecal adjuvants like magnesium suphate and nalbuphine (opiod) for spinal anaesthesia with hyperbaric bupivacaine 0.5% ,in view to intensify and increase the duration of sensory blockade, thus prolonging the duration of post operative analgesia in lower limb and lower abdominal surgeries.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
ASA physical status 1 and 2 Elective lower limb and lower abdominal surgeries.
Exclusion Criteria
- Patients posted for emergencies.
- Patients allergic to local anaesthetics.
- Patients with severe cardiovascular , renal , respiratory and endocrinal disorders.
- Patients with coagulation disorders and local sepsis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of intrathecal adjuvants like magnesium sulphate and nalbuphine (opiod) for spinal anaesthesia with hyperbaric bupivacaine 0.5% in view to intensify and increase the duration of sensory blockade thus prolonging the duration of post operative analgesia in lower limb and lower abdominal surgeries. From the time patient is shifted to operation theatre upto 24 hours post surgery.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kempegowda institute of medical sciences
🇮🇳Bangalore, KARNATAKA, India
Kempegowda institute of medical sciences🇮🇳Bangalore, KARNATAKA, IndiaDr BhavanaPrincipal investigator9535755274madhurulesu@gmail.com